Skip to main content

Table 2 Quality of life according to mean scales of WHQ at the end of the first trial year, EPHT Trial

From: The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial

Variable Non-HT arms HT arms p-value* p-value
  Mean
(SE)
Mean
(SE)
  
Depressed mood 0.22
(0.01)
0.21
(0.01)
0.308 0.539
Somatic symptoms 0.40
(0.01)
0.39
(0.01)
0.212 0.282
Memory/concentration 0.42
(0.01)
0.41
(0.01)
0.447 0.490
Vasomotor symptoms 0.36
(0.01)
0.21
(0.01)
<0.0001 <0.0001
Anxiety/fear 0.27
(0.01)
0.27
(0.01)
0.519 0.642
Sexual behaviour 0.46
(0.02)
0.36
(0.02)
0.001 <0.001
Sleep problems 0.39
(0.01)
0.34
(0.01)
0.005 0.005
Menstrual symptoms 0.25
(0.01)
0.28
(0.01)
0.027 0.017
Attractiveness 0.53
(0.01)
0.53
(0.01)
0.811 0.791
  1. * Wilcoxon rank sum test.
  2. t-test.